Skip to main content
. 2017 May 17;6(5):e005479. doi: 10.1161/JAHA.117.005479

Table 2.

Association of Each Cardiometabolic Component, Their Clustering, and MetS With All‐Cause and Cardiovascular/Cerebrovascular Mortality

All‐Cause CVD/CBV
HR (95% CI) P Value HR (95% CI) P Value
No. of deaths 348 147
Individual components
Obesity 1.15 (0.91–1.45)a 0.25 1.32 (0.90–1.93)a 0.16
Hypercholesterolemia 0.87 (0.69–1.10)a 0.22 1.22 (0.86–1.70)a 0.26
Hypertriglyceridemia 1.11 (0.89–1.38)a 0.37 1.12 (0.79–1.52)a 0.52
Glucose dysregulation 1.38 (1.10–1.76)a <0.01b 1.18 (0.83–1.70)a 0.34
High blood pressure 1.43 (1.12–1.84)a <0.01b 1.51 (1.01–2.29)a 0.05b
Cumulative no. of components
0 1.00 1.00
1 0.96 (0.62–1.50) 0.87 0.53 (0.25–1.15) 0.11
2 0.90 (0.59–1.37) 0.59 0.70 (0.36–1.37) 0.29
3 1.75 (1.18–2.61) <0.01b 1.27 (0.66–2.42) 0.47
4 1.79 (1.01–3.20) 0.05b 1.51 (0.78–2.94) 0.22
5 2.24 (1.32–3.79) <0.01b 1.78 (0.74–4.29) 0.20
MetS
No (<3 components) 1.00
Yes (≥3 components) 1.73 (1.40–2.14)c , d <0.01b 1.92 (1.35–2.74)c <0.01b

CBV indicates cerebrovascular; CVD, cardiovascular disease; HR, hazard ratio; MetS, metabolic syndrome; SDB, sleep disordered breathing.

a

Hazard ratios (95% CIs) adjusted for one another as well as for age, race, sex, smoking, alcohol use, depression, insomnia, SDB, heart disease, stroke, and objective sleep duration.

b

P<0.05.

c

Hazard ratios (95% CIs) adjusted for age, race, sex, smoking, depression, insomnia, SDB, heart disease, stroke, and objective sleep duration.

d

P value for MetS×objective sleep duration interaction <0.05. All data adjusted by sampling weight. Obesity=body mass index ≥30 m2/kg. Hypercholesterolemia=elevated total cholesterol levels (≥200 mg/dL). Hypertriglyceridemia=elevated triglycerides levels (≥150 mg/dL). Glucose dysregulation=elevated fasting glucose levels (≥100 mg/dL) or treatment for diabetes mellitus. High blood pressure=elevated blood pressure levels (≥130/85 mm Hg) or antihypertensive treatment.